Anthropic IPO Could Anchor Valuations for Asian AI Labs
nashnova research
Anthropic listed on Nasdaq this week, becoming the first frontier AI-model company to go public independently; this first-ever public benchmark will directly shape valuation ceilings for Moonshot AI, DeepSeek, and other Asian AI labs lining up to list.
Why does this IPO matter far beyond Anthropic itself?
Anthropic is the first frontier AI-model company to list on a U.S. exchange as a standalone entity. This means → public investors now have, for the first time, a live price signal on AI-lab revenue growth versus compute costs.
Before this, AI-lab valuations existed only in private fundraising rounds — no publicly traded reference point. In plain terms = once Anthropic trades, every comparable company has a visible yardstick.
Asia's Moonshot AI, DeepSeek, and Sakana AI are all queuing to list. Their pricing will be measured directly against this yardstick.
What do Anthropic's own numbers look like?
Revenue growth has been explosive: from $386 million in 2024 to $4.6 billion in 2025, then $33.2 billion in the first three quarters of 2026 — with Q3 alone at $17 billion.
Over 70% of revenue comes from usage fees billed by compute consumption; the rest is Claude subscription revenue.
Losses are equally massive: net loss exceeded $104 billion in the first nine months of 2026, as compute and infrastructure spending surged from $4.4 billion to $18.8 billion year-on-year. This means → revenue is exploding, but the compute bill is growing even faster — whether revenue can outrun that bill is the central question after listing.
Why did the valuation compress from $2 trillion to $1.2 trillion?
Anthropic's valuation has fallen from the $2 trillion-plus range rumored at the start of the year to roughly $1.2–1.4 trillion, implying a share price of $70–78.
Three headwinds converged: post-midterm Democratic victories raised expectations of tighter AI regulation; Nvidia CEO Jensen Huang resigned over a scandal; and a broader debate over AI investment returns dragged U.S., Japanese, and Korean tech stocks lower over the past month.
In plain terms = Anthropic didn't get worse — the entire AI sector's sentiment turned cold, and the macro environment pushed the price tag down.
Which Asian AI labs are in the queue?
Moonshot AI (Beijing): valued at roughly $50 billion after its latest round; Bloomberg reports it plans a Hong Kong IPO raising up to $5 billion. The company declined to comment.
DeepSeek is preparing a Shanghai listing; AMD-backed South Korean startup Upstage AI plans to list in Korea; Japan's Sakana AI could list as early as autumn 2027, per Nikkei.
In Hong Kong, Zhipu AI completed its listing in January — the largest AI-company IPO in Asia-Pacific this year.
Can this yardstick really be applied directly to Asian companies?
CLSA head of international tech research Bhavtosh Vajpayee ranks the Anthropic listing among the market's "clearing events," alongside TSMC's capex guidance for next year and hyperscaler AI-infrastructure budgets for 2027 — arguing these three milestones will together answer how long the AI up-cycle lasts.
PitchBook Asia-Pacific private-capital director Ansel Tan says a smooth listing would boost public-market confidence in frontier AI's commercial potential and raise the valuation bar for Asian labs.
But he stresses that Asian labs differ from Anthropic in market environment, regulatory framework, and business model — direct comparisons don't hold. This means → whether Anthropic's price survives the secondary-market test is the prerequisite for this yardstick to work at all. A ruler that hasn't been calibrated itself can't reliably measure anyone else.
市场有风险,内容仅供研究参考,不构成投资建议。
